MoonLake Immunotherapeutics (MLTX) Insider Trading & Ownership $51.18 -2.08 (-3.91%) Closing price 09/17/2025 04:00 PM EasternExtended Trading$51.50 +0.32 (+0.63%) As of 09/17/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MoonLake Immunotherapeutics (NASDAQ:MLTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.02%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$9.19M Get MLTX Insider Trade Alerts Want to know when executives and insiders are buying or selling MoonLake Immunotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLTX Insider Buying and Selling by Quarter MoonLake Immunotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/4/2024Simon SturgeDirectorSell171,000$53.72$9,186,120.00 (Data available from 1/1/2013 forward) MLTX Insider Trading Activity - Frequently Asked Questions Who is on MoonLake Immunotherapeutics' Insider Roster? The list of insiders at MoonLake Immunotherapeutics includes Bihua Chen, Da Silva Jorge Santos, Kristian Reich, Matthias Bodenstedt, and Simon Sturge. Learn more on insiders at MLTX. What percentage of MoonLake Immunotherapeutics stock is owned by insiders? 12.02% of MoonLake Immunotherapeutics stock is owned by insiders. Learn more on MLTX's insider holdings. Which MoonLake Immunotherapeutics insiders have been buying company stock? The following insider purchased MLTX shares in the last 24 months: Bihua Chen ($8,184,742.55). How much insider buying is happening at MoonLake Immunotherapeutics? Insiders have purchased a total of 142,725 MLTX shares in the last 24 months for a total of $8,184,742.55 bought. Which MoonLake Immunotherapeutics insiders have been selling company stock? The following insiders have sold MLTX shares in the last 24 months: Da Silva Jorge Santos ($6,071,868.60), Kristian Reich ($3,418,805.00), Matthias Bodenstedt ($5,610,265.92), and Simon Sturge ($9,186,120.00). How much insider selling is happening at MoonLake Immunotherapeutics? Insiders have sold a total of 432,717 MoonLake Immunotherapeutics shares in the last 24 months for a total of $24,287,059.52 sold. MoonLake Immunotherapeutics Key ExecutivesDr. Jorge Santos da Silva (Age 46)Co-Founder, CEO & Director Compensation: $1.11MDr. Kristian Reich (Age 58)Co-Founder & Chief Scientific Officer Compensation: $1.2MMr. Matthias Bodenstedt (Age 36)Chief Financial Officer Compensation: $588.25kMr. Oliver DaltropChief Technical OfficerNicolas MosimannGeneral CounselLuciana MarquesDirector of HR, People & CultureMs. Nuala BrennanChief Clinical Development Officer More Insider Trading Tools from MarketBeat Related Companies VTRS Insider Trading BBIO Insider Trading ROIV Insider Trading ELAN Insider Trading MRNA Insider Trading VRNA Insider Trading RVMD Insider Trading GRFS Insider Trading RYTM Insider Trading CYTK Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NASDAQ:MLTX) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTen Bucks, Five Minutes... Could Send You Up to $8K QUARTERLYDOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredWhy Peter Thiel Hid Gold in a VaultSilicon Valley billionaires hiding gold in vaults? Peter Thiel’s Palantir quietly diverted tens of millions...Golden Portfolio | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MoonLake Immunotherapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share MoonLake Immunotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MLTX Stock Alerts